Literature DB >> 8540709

Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni.

E Charvalos1, Y Tselentis, M M Hamzehpour, T Köhler, J C Pechere.   

Abstract

Mechanisms of drug resistance in Campylobacter jejuni were investigated. Mutant strains 34PEFr, which was resistant to pefloxacin (128-fold increase in the MIC), and 34CTXr, which was resistant to cefotaxime (32-fold increase in the MIC) and which was derived from the susceptible parent 34s, were obtained by serial passages on pefloxacin and cefotaxime gradient plates, respectively. Both mutants showed cross-resistance to erythromycin, chloramphenicol, tetracycline, beta-lactams, and quinolones. While the quinolone resistance of strain PEFr could be explained by a mutation at codon 86 of the gyrA gene, the multidrug resistance phenotype of both strains was further investigated. Accumulation of pefloxacin, ciprofloxacin, and minocycline was measured by fluorometry and was found to be lower in the mutant strains than in the parent strain. Preincubation of the cells with carbonyl cyanide m-chlorophenylhydrazone, however, completely abolished this difference. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of outer membrane preparations from both mutant strains showed overexpression of two proteins of 55 and 39 kDa which were absent from the outer membranes of the wild-type strain. These results indicate that in C. jejuni 34PEFr and 34CTXr, multidrug resistance is associated with an efflux system with a broad specificity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540709      PMCID: PMC162874          DOI: 10.1128/AAC.39.9.2019

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

Review 1.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli.

Authors:  S W Shales; I Chopra; P R Ball
Journal:  J Gen Microbiol       Date:  1980-11

Review 4.  Campylobacter enteritis.

Authors:  M J Blaser; L B Reller
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

5.  Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.

Authors:  D E Taylor; L K Ng; H Lior
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

Review 6.  Current problems in antimicrobial therapy for bacterial enteric infection.

Authors:  H L DuPont; C D Ericsson; A Robinson; P C Johnson
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  Outer membrane characteristics of Campylobacter jejuni.

Authors:  S M Logan; T J Trust
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Routes of quinolone permeation in Escherichia coli.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

9.  Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.

Authors:  Y Wang; W M Huang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline.

Authors:  A M George; S B Levy
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

View more
  20 in total

Review 1.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 3.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

4.  Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.

Authors:  V Zeller; C Janoir; M D Kitzis; L Gutmann; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Diagnosis of quinolone-resistant Coxiella burnetii strains by PCR-RFLP.

Authors:  I Spyridaki; A Psaroulaki; A Aransay; E Scoulica; Y Tselentis
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Beilei Ge; Patrick F McDermott; David G White; Jianghong Meng
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF.

Authors:  Lilian Pumbwe; Luke P Randall; Martin J Woodward; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

8.  Antimicrobial-resistant Campylobacter species from retail raw meats.

Authors:  Beilei Ge; David G White; Patrick F McDermott; Webb Girard; Shaohua Zhao; Susannan Hubert; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

9.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

10.  Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.

Authors:  A Gibreel; E Sjögren; B Kaijser; B Wretlind; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.